Abstract
AbstractBackgroundMigraine is the most common neurological disease. Recently, there is a wide variety of prophylactic drugs, but their effects differ among individuals.AimTo investigate clinical factors affecting the response to amitriptyline therapy and establish a scoring system for predicting the negative response to prophylactic therapy.MethodsWe examined clinical factors from medical records of 29 consistent responders (CRs) and 21 inconsistent responders (IRs) to amitriptyline.ResultsMultivariate analysis revealed that a past history of medication overuse headache (MOH) and allodynia from associated symptoms were significant factors that independently contributed to a negative response. Odds ratio of MOH was 4.489 (no vs yes; 95% CI = 1.109–14.224), and odds ratio of allodynia was 4.489 (yes vs no; 95% CI = 1.109–14.224). A predictive index (PI) of the negative response to amitriptyline in patients with migraine was calculated using the regression coefficients of these two factors as integers, and the index was significantly higher for IRs than CRs (1.33 ± 0.58 vs 0.76 ± 0.69, mean ± SD, P = 0.003)ConclusionThe obtained PI may represent an appropriate scoring system for negative responses in patients using amitriptyline.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
